304 related articles for article (PubMed ID: 24395596)
1. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma.
Gutschner T; Hämmerle M; Pazaitis N; Bley N; Fiskin E; Uckelmann H; Heim A; Groβ M; Hofmann N; Geffers R; Skawran B; Longerich T; Breuhahn K; Schirmacher P; Mühleck B; Hüttelmaier S; Diederichs S
Hepatology; 2014 May; 59(5):1900-11. PubMed ID: 24395596
[TBL] [Abstract][Full Text] [Related]
2. Modulation of IGF2BP1 by long non-coding RNA HCG11 suppresses apoptosis of hepatocellular carcinoma cells via MAPK signaling transduction.
Xu Y; Zheng Y; Liu H; Li T
Int J Oncol; 2017 Sep; 51(3):791-800. PubMed ID: 28677801
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA NBAT1 suppresses hepatocellular carcinoma progression via competitively associating with IGF2BP1 and decreasing c-Myc expression.
Wei L; Ling M; Yang S; Xie Y; Liu C; Yi W
Hum Cell; 2021 Mar; 34(2):539-549. PubMed ID: 33387362
[TBL] [Abstract][Full Text] [Related]
4. LIN28B-AS1-IGF2BP1 binding promotes hepatocellular carcinoma cell progression.
Zhang J; Hu K; Yang YQ; Wang Y; Zheng YF; Jin Y; Li P; Cheng L
Cell Death Dis; 2020 Sep; 11(9):741. PubMed ID: 32917856
[TBL] [Abstract][Full Text] [Related]
5. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
Zhang J; Cheng J; Zeng Z; Wang Y; Li X; Xie Q; Jia J; Yan Y; Guo Z; Gao J; Yao M; Chen X; Lu F
Oncotarget; 2015 Dec; 6(39):42040-52. PubMed ID: 26547929
[TBL] [Abstract][Full Text] [Related]
7. Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation.
Lin XT; Yu HQ; Fang L; Tan Y; Liu ZY; Wu D; Zhang J; Xiong HJ; Xie CM
Elife; 2021 Nov; 10():. PubMed ID: 34779401
[TBL] [Abstract][Full Text] [Related]
8. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
[TBL] [Abstract][Full Text] [Related]
9. A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA.
He J; Zuo Q; Hu B; Jin H; Wang C; Cheng Z; Deng X; Yang C; Ruan H; Yu C; Zhao F; Yao M; Fang J; Gu J; Zhou J; Fan J; Qin W; Yang XR; Wang H
Cancer Lett; 2019 May; 450():98-109. PubMed ID: 30790682
[TBL] [Abstract][Full Text] [Related]
10. SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.
Ran LK; Chen Y; Zhang ZZ; Tao NN; Ren JH; Zhou L; Tang H; Chen X; Chen K; Li WY; Huang AL; Chen J
Clin Cancer Res; 2016 Jul; 22(13):3372-82. PubMed ID: 26861461
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressive function of IGF2BP1 in gastric cancer through decreasing MYC.
Ding N; Cao G; Wang Z; Xu S; Chen W
Cancer Sci; 2024 Feb; 115(2):427-438. PubMed ID: 38115228
[TBL] [Abstract][Full Text] [Related]
13. Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1).
Hämmerle M; Gutschner T; Uckelmann H; Ozgur S; Fiskin E; Gross M; Skawran B; Geffers R; Longerich T; Breuhahn K; Schirmacher P; Stoecklin G; Diederichs S
Hepatology; 2013 Nov; 58(5):1703-12. PubMed ID: 23728852
[TBL] [Abstract][Full Text] [Related]
14. SOX12 upregulation is associated with metastasis of hepatocellular carcinoma and increases CDK4 and IGF2BP1 expression.
Yuan P; Meng L; Wang N
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3821-3826. PubMed ID: 28975985
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor 2 mRNA-binding protein 1 promotes cell proliferation
Wan BS; Cheng M; Zhang L
World J Gastroenterol; 2019 Oct; 25(40):6063-6076. PubMed ID: 31686763
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability.
Yang F; Xue X; Zheng L; Bi J; Zhou Y; Zhi K; Gu Y; Fang G
FEBS J; 2014 Feb; 281(3):802-13. PubMed ID: 24397586
[TBL] [Abstract][Full Text] [Related]
17. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
18. mTORC2 deploys the mRNA binding protein IGF2BP1 to regulate c-MYC expression and promote cell survival.
Lambrianidou A; Sereti E; Soupsana K; Komini C; Dimas K; Trangas T
Cell Signal; 2021 Apr; 80():109912. PubMed ID: 33388443
[TBL] [Abstract][Full Text] [Related]
19. A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability.
Zhu P; He F; Hou Y; Tu G; Li Q; Jin T; Zeng H; Qin Y; Wan X; Qiao Y; Qiu Y; Teng Y; Liu M
Oncogene; 2021 Mar; 40(9):1609-1627. PubMed ID: 33469161
[TBL] [Abstract][Full Text] [Related]
20. LncRNA THOR acts as a retinoblastoma promoter through enhancing the combination of c-myc mRNA and IGF2BP1 protein.
Shang Y
Biomed Pharmacother; 2018 Oct; 106():1243-1249. PubMed ID: 30119193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
